Reproducibility and validity of patient-rated assessment of speech, swallowing, and saliva control in Parkinson's disease

Kalf JG, Borm GF, de Swart BJ, Bloem BR, Zwarts MJ, Munneke M. Reproducibility and validity of patient-rated assessment of speech, swallowing, and saliva control in Parkinson's disease.

Objective

To report on the development and psychometric evaluation of the Radboud Oral Motor Inventory for Parkinson's Disease (ROMP), a newly developed patient-rated assessment of speech, swallowing, and saliva control in patients with Parkinson's disease (PD).

Design

Reliability and validity study.

Setting

Tertiary-care Parkinson center for multidisciplinary assessment.

Participants

Consecutive community-dwelling patients with PD (n=129) or atypical parkinsonism (AP; n=49; mean ± SD age, 64±9.8y; mean ± SD disease duration, 7y; median Hoehn and Yahr [HY] stage, 2.5).

Interventions

Not applicable.

Main Outcome Measures

To evaluate reproducibility, 60 patients completed the ROMP twice within a mean of 24±12 days. To study validity, another cohort of 118 patients who had completed the ROMP was assessed by both a neurologist (HY stage, Unified Parkinson's Disease Rating Scale III) and speech-language pathologist (severity of dysarthria, dysphagia, drooling) who were blinded to ROMP scores.

Results

Confirmatory factor analysis identified the 3 a priori–designed ROMP domains of speech, swallowing, and saliva control. Internal consistency was .95 for the total ROMP and .87 to .94 for the 3 domains or subscales. Intraclass correlation coefficients for reproducibility were .94 and .83 to .92 for the subscales. Construct validity was substantial to good with correlations ranging from .36 to .82. The ROMP differentiated significantly (P<.001) between patients indicated for speech therapy (based on independent assessment) and those who were not and between mild, moderate, and severe PD according to HY stage.

Conclusions

The ROMP provides a reliable and valid instrument to evaluate patient-perceived problems with speech, swallowing, and saliva control in patients with PD or AP.     

脑梗死后认知-情感、感觉缺损对吞咽功能恢复的影响

目的：探讨认知功能缺损、感觉障碍对脑梗死伴吞咽功能障碍并进行吞咽功能训练的患者吞咽功能恢复的影响.方法：34例脑梗死并发摄食-吞咽功能障碍患者,根据MMSE认知功能评定将患者分为吞咽功能障碍合并认知功能缺损组16例（A组）,单纯吞咽功能障碍组18（B组）.B组患者给予吞咽功能训练并行针灸治疗,A组在B组治疗方法的基础上进行认知功能的评定、训练和心理疏导.结果：治疗前洼田氏评分A组与B组比较差异有显著性意义（P＜0.05）,1个月后两组吞咽评定与自身治疗前相比差异有显著性意义（P＜0.05）,但两组间洼田氏评分比较差异无显著性意义（P＞0.05）.治疗前A组的颜面失用/流涎、失语、口腔感觉程度与B组相比差异有显著性意义（P＜0.05）;A组在认知功能训练后MMSE评定与自身治疗前相比有明显提高（P＜0.05）,治疗前后认知功能评分与吞咽障碍等级均呈负相关（相关系数分别为：-0.650和-0.51）.结论：脑梗死后认知功能缺损的存在可加重吞咽功能障碍的程度,认知功能的改善可促进吞咽功能的恢复.     

Does levodopa improve swallowing dysfunction in Parkinson’s disease patients?

Objective:  To assess the influence of levodopa on swallowing dysfunction in Parkinson's disease patients.
Methods:  A systematic review of the literature and a meta-analysis were performed. All studies referring to levodopa and swallowing dysfunction that provided direct data or data that could be transformed into mean ± standard deviation were considered for analysis. The primary efficacy variables were Oral Transit Time (OTT), Pharyngeal Transit Time (PTT) for both thin fluids and solids, and aspiration.
Results:  Seven studies describing swallowing functions in PD patients using levodopa were found, and five of these matched the inclusion criteria. No clinically meaningful improvement after levodopa intake was noted. Adverse effects were not reported by the authors.
Conclusion:  This meta-analysis shows that levodopa intake was not associated with an improvement of swallowing dysfunction in Parkinson's disease patients.     

Regaining water swallowing function in the rehabilitation of critically ill patients with intensive-care-unit acquired muscle weakness

Purpose: Treatment in intensive care units (ICUs) often results in swallowing dysfunction. Recent longitudinal studies have described the recovery of critically ill people, but we are not aware of studies of the recovery of swallowing function in patients with ICU-acquired muscle weakness. This paper aims to describe the time course of regaining water swallowing function in patients with ICU-acquired weakness in the post-acute phase and to describe the risks of regaining water swallowing function and the risk factors involved.

Methods: This cohort study included patients with ICU-acquired muscle weakness in our post-acute department, who were unable to swallow. We monitored the process of regaining water swallowing function using the 3-ounce water swallowing test.

Results: We included 108 patients with ICU-acquired muscle weakness. Water swallowing function was regained after a median of 12?days (interquartile range =17) from inclusion in the study and after a median of 59?days (interquartile range=?36) from the onset of the primary illness. Our multivariate Cox Proportional Hazard model yielded two main risk factors for regaining water swallowing function: the number of medical tubes such as catheters at admission to the post-acute department (adjusted hazard ratio [HR]?=?1.282; 95% confidence interval [CI]: 1.099–1.495) and the time until weaning from the respirator in days (adjusted HR =1.02 per day; 95%CI: 0.998 to 1.008).

Conclusion: We describe a time course for regaining water swallowing function based on daily tests in the post-acute phase of critically ill patients. Risk factors associated with regaining water swallowing function in rehabilitation are the number of medical tubes and the duration of weaning from the respirator.

• Implications for rehabilitation

• Little guidance is available for the management of swallowing dysfunction in the rehabilitation of critically ill patients with intensive-care-units acquired muscle weakness.

• There is a time dependent pattern of recovery from swallowing dysfunction with daily water swallowing tests in the post-acute phase of critically ill patients.

• Daily water swallowing tests can be used to test swallowing dysfunction in the post-acute phase of critically ill patients

• The amount of medical tubes and the duration of weaning from respirator are associated risk factors for recovery of swallowing dysfunction.

     

家庭吞咽训练计划对头颈部肿瘤放疗患者吞咽功能的效果北大核心CSCD

目的探讨家庭吞咽训练计划对头颈部肿瘤放疗患者吞咽功能的改善作用。方法选取2020年9月至2021年9月北大荒集团总医院肿瘤科接受放疗的头颈部肿瘤患者45例,随机分为对照组(n=23)和观察组(n=22)。对照组采用常规治疗,观察组在对照组的基础上,进行14周的吞咽训练计划,包括在院期间6周的个体化指导训练和离院后8周的居家式训练。分别于训练前、训练6周和训练14周,比较两组门齿距、体质量、洼田饮水试验(WST)和功能性经口摄食量表(FOIS)评分。结果训练前,两组门齿距、体质量、WST和FOIS评分均无显著性差异(P>0.05)。训练6周和14周,观察组门齿距、WST和FOIS评分均优于对照组(|Z|>2.332,P<0.05)。结论家庭吞咽训练计划有利于改善放疗引起的张口受限、吞咽困难情况,且家庭吞咽训练计划简单、安全、经济,操作性强,值得临床推广。     

功能训练辅以营养干预治疗脑卒中后吞咽功能障碍的临床观察

目的:观察功能训练辅以营养干预治疗脑卒中后吞咽功能障碍的效果。方法:将脑卒中后吞咽功能障碍患者80例随机分为2组各40例,2组均进行吞咽功能训练,对照组给予常规肠内营养支持,观察组辅以全营养型个体化营养干预治疗,治疗前、后均行洼田饮水试验评价吞咽功能改善情况,并检查总蛋白(TP)、白蛋白(ALB)、前白蛋白(Hb)、体重、三头肌皮褶厚度、上臂围、上臂肌围变化,记录并发症发生情况。结果:治疗4周后,2组患者VFSS评分均较治疗前明显提高(P0.05),且观察组VFSS评分高于对照组(P0.05)。观察组并发症发生率明显低于对照组(P0.05)。治疗后,对照组患者TP、ALB、Hb较治疗前及观察组治疗后明显降低(P0.05),观察组上述指标治疗前后差异无统计学意义。治疗后,对照组体重指数、肱三头肌皮褶厚度、上臂肌围较治疗前及观察组治疗后明显降低(P0.05),观察组上述指标治疗前后比较差异无统计学意义。结论:功能训练辅以营养干预治疗脑卒中后吞咽功能障碍更系统化、科学化,是提高康复效果,改善患者营养状况,降低并发症发生率的有效方法。     

A comparison of swallowing dysfunction in Becker muscular dystrophy and Duchenne muscular dystrophy

Purpose: Swallowing dysfunction has been reported in Duchenne muscular dystrophy (DMD), but has not been studied in Becker muscular dystrophy (BMD). The aims of this study were to report the characteristics of swallowing dysfunction in BMD compared with DMD.

Materials and methods: The study participants were 18 patients with BMD and 18 patients with DMD. All the patients were examined using videofluorography during swallowing of 5?mL of fluid. The penetration–aspiration scale (P–A scale) and the videofluorographic dysphagia scale (VDS) were used to evaluate dysphagia.

Results: Swinyard functional ability stage was not significantly different between the BMD and DMD groups. Rate of aspiration, P–A scale score, and total VDS score did not differ across groups, but the VDS item score for laryngeal elevation was lower in the BMD group than in the DMD group (median scores 4.5 and 9, respectively; p?r?=?0.78, p?Conclusion: Patients with BMD have swallowing problems similar to those observed in patients with DMD when matched according to physical functional status. These patients should be evaluated and followed-up for the duration of their disease.

• Implications for rehabiliation

• Dysphagia is one of the most critical problems in patients with progressive neuromuscular disease but dysphagia in patients with Becker muscular dystrophy (BMD) was not well known.

• Eighteen patients with BMD and 18 patients with Duchenne muscular dystrophy were examined with videofluorography.

• Patients with BMD have swallowing problems similar to those observed in patients with DMD.

     

Efficacy of swallowing training for residents following stroke

BACKGROUND: The presence of dysphagia is associated with an increased risk of mortality, malnutrition, dehydration, compromised pulmonary function, and disability. Appropriate swallowing training can establish optimal nutritional status and eliminate or reduce the risk of developing medical complications associated with swallowing impairment. AIM(S) OF THE STUDY: The aim of this study was to examine the functional swallowing and nutritional outcomes of swallowing training in institutionalized stroke residents with dysphagia. DESIGN AND METHODS: A quasi-experimental parallel cluster design was used. Seven institutions with similar bed sizes were selected. All subjects in the experimental group received a structured swallowing training programme. The subjects in the experimental group (n = 40) received 30 minutes of swallowing training each day for 6 days per week for 8 weeks. The control group (n = 21) did not receive any training. RESULTS: After swallowing training, mean differences in volume per second, volume per swallow, mid-arm circumference and body weight between pre- and post-training of the experimental group were significantly higher than for the control group, while mean differences in neurological examination and choking frequency during meals for the experimental group were significantly lower than in the control group. CONCLUSION: This study used objective timed swallowing tests, a swallowing questionnaire, and a neurological examination to evaluate the effects of swallowing training. However, videofluroscopy is generally considered the best method for evaluating the pharyngeal and esophageal stages of swallowing, and introducing this technique is recommended for future studies. Furthermore, it is recommended that nursing professionals should conduct swallowing training protocols in stroke patients to help prevent aspiration from dysphagia.     

预见性护理联合标准吞咽功能评估在老年脑卒中吞咽障碍患者中的临床应用

目的 探讨预见性护理联合标准吞咽功能评估在老年脑卒中吞咽障碍患者中的临床应用效果.方法 选取2014年10月~2016年1月于该院就诊的151例老年脑卒中吞咽障碍患者为研究对象,A组77例患者采用预见性护理联合标准吞咽功能评估的治疗方案,B组74例患者仅给予神经内科常规的治疗护理和基本的康复训练.对比两组患者的肺部感染、吸入性肺炎、住院时间和费用,治疗效果,以及治疗前后的各项营养指标.结果 A组中有2例(2.60%)患者发生了肺部感染,明显少于B组8例(10.81%)(χ 2=4.116 5,P=0.0425);A组中有8例(10.39%)患者发生了吸入性肺炎,明显少于B组的25例(33.78%)(χ 2=12.092 6,P=0.000 5);A组患者的平均住院时间为(12.89±2.27)d,明显少于B组(19.32±3.58)d(t=13.234 4,P=0.000 0);A组患者的平均住院费用为(1.92±0.35)万元,明显低于B组(2.89±0.61)万元(t=12.043 4,P=0.000 0);A组患者的总有效率为92.21%,明显高于B组70.27%(χ 2=12.023 0,P=0.000 5);治疗后A组患者的各项营养指标均明显优于B组(均P<0.05).结论 对于老年脑卒中吞咽障碍患者,采用预见性护理联合标准吞咽功能评估的治疗方案疗效好,治愈率高、肺部感染少、吸入性肺炎发生率低、恢复快.     

高频rTMS作用健侧半球吞咽皮质代表区联合吞咽康复训练治疗脑卒中后吞咽障碍的临床研究

目的:探讨高频重复经颅磁刺激(rTMS)作用于健侧半球吞咽皮质代表区联合吞咽康复训练治疗脑卒中后吞咽障碍的疗效.方法:将82例缺血性脑卒中后吞咽障碍患者随机分为2组.对照组(41例)采用吞咽康复训练治疗,观察组(41例)采用高频rTMS作用于健侧半球吞咽皮质代表区联合吞咽康复训练治疗,均治疗4周.观察2组疗效,吞咽障碍...     

脑卒中患者吞咽障碍的喂食指导与康复训练的护理

目的探讨喂食指导与吞咽功能训练护理对脑卒中患者吞咽障碍的临床效果。方法选取本院2011年4月-2012年6月收治的156例脑卒中吞咽障碍的患者,随机分为试验组（78例）和对照组（78例）,对照组采用常规治疗,试验组在对照组的基础上实施喂食指导与吞咽功能训练,治疗30d后评价治疗疗效和洼田饮水试验改善程度。结果试验组总有效率明显高于对照组,2组差异具有统计学意义（P〈0．01）。2组洼田饮水试验均较治疗前有改善,但试验组改善程度明显高于对照组,2组差异具有统计学意义（P〈0．01）。结论对急性脑卒中并发吞咽障碍患者进行喂食指导与吞咽功能训练,对改善患者吞咽困难程度有重要意义。     

在电视X线透视吞咽功能检查指导下进行治疗性进食结合吞咽训练对脑卒中后吞咽障碍患者功能的影响

目的:探讨在电视X线透视吞咽功能检查(VFSS)指导下进行治疗性进食结合吞咽训练对脑卒中后吞咽障碍的疗效。方法:选取脑卒中后留置胃管的吞咽障碍患者60例,随机分为对照组和观察组各30例,2组入院后都进行VFSS,对照组给予常规吞咽训练,观察组给予吞咽训练后进行治疗性进食,每周5d,共3周。2组患者分别于治疗前后进行洼田饮水试验(WST),渗漏-误吸分级(PAS)及功能性经口摄食评估(FIOS),并比较2组患者拔管率、患者出院后咳嗽咳痰情况。结果:治疗前,2组患者WST、PAS、FIOS结果比较差异无统计学意义,治疗3周后,对照组WST、PAS分级情况改善(P<0.01,0.05),FIOS等级无明显变化;观察组各项评分较治疗前均有改善(均P<0.01),与对照组相比,观察组3项评估指标、拔管率均有显著改善(均P<0.01),出院1个月后咳嗽咳痰情况有显著改善(P<0.01)。结论:在VFSS指导下进行治疗性进食结合吞咽训练能显著改善脑卒中后吞咽障碍患者的吞咽功能。     

吞咽动作观察疗法对脑卒中患者吞咽功能和功能性磁共振成像的影响

目的:观察吞咽动作观察疗法对脑卒中后吞咽障碍患者吞咽功能和功能性磁共振成像的影响。方法:将脑卒中后吞咽障碍患者18例按随机数字表法分为治疗组(9例)和对照组(9例)。治疗组在常规吞咽康复治疗的基础上,观看正常人吞咽动作视频,然后模仿吞咽动作,对照组则在常规吞咽康复治疗的基础上,观看相同时间的风景视频,每周5次,每次10...     

吞咽功能障碍治疗仪对脑梗死吞咽功能障碍的治疗效果

目的观察吞咽功能障碍治疗仪治疗脑梗死合并吞咽障碍的效果。方法将70例脑梗死合并球麻痹所致吞咽障碍患者按随机数字表法随机分为对照组和治疗组各35例,两组均给予常规的吞咽功能康复训练、直接摄食训练、心理暗示等治疗,而治疗组在此基础上再加用吞咽功能障碍治疗仪实施治疗,比较两组治疗效果。结果治疗前两组患者吞咽能力评分、洼田饮水评分比较差异无统计学意义（P〉0．05）;治疗后治疗组吞咽能力评分情况为1分15例（42．9％）,2分10例（28．6％）,3分6例（17．1％）,4分4例（11．4％）,与对照组比较差异有统计学意义（Z=-2．159,P〈0．05）;治疗后两组洼田饮水评分比较差异有统计学意义（P〈0．05）;治疗总有效率比较治疗组（88．6％）高于对照组（65．7％）,差异有统计学意义（Z=-2．351,P〈0．05）。结论吞咽功能障碍治疗仪对脑梗死合并球麻痹有显著疗效,而且安全、方便、无痛苦。     

吞咽功能训练降低颅脑损伤气管切开患者肺部感染的临床研究

目的探讨吞咽功能训练降低颅脑损伤气管切开患者肺部感染的临床疗效。方法选择124例颅脑损伤患者,按照随机数字法分为实验组与对照组,对照组采取常规治疗,实验组则在对照组的基础上采取吞咽功能训练,采集2组肺部感染患者分泌物标本进行细菌培养、鉴定及药敏实验,并比较2组患者吞咽功能、肺部感染率及置管时间。结果通过培养、分离共从43例肺部感染患者中检出223株病原菌,其中革兰阳性菌65株(29.15%),革兰阴性菌148株(66.37%),真菌18株(8.07%)。金黄色葡萄球菌对青霉素G、氨苄西林的耐药率均>87%,对万古霉素、利福平、克林霉素敏感;粪肠球菌对环丙沙星、青霉素G耐药;表皮葡萄球菌对万古霉素、利福平、克林霉素敏感。鲍氏不动杆菌、铜绿假单胞菌、肺炎克雷伯菌对头孢他啶、头孢噻肟、氧氟沙星均有较高的耐药率,而对亚胺培南、美罗培南敏感;而鲍氏不动杆菌及肺炎克雷伯均对哌拉西林/他唑巴坦、头孢哌酮/舒巴坦耐药率<30%;铜绿假单胞菌具有耐药较为广泛,仅对亚胺培南、美罗培南敏感。治疗后,实验组优良率显著优于治疗前及对照组(P<0.05)。实验组肺部感染率及置管时间均显著优于对照组(P<0.05)。结论颅脑损伤气管切开患者行吞咽功能训练有效可降低肺部感染,缩短置管时间,改善预后。     

不同术式对喉部分切除术患者吞咽功能的影响

目的探讨不同术式对喉部分切除术患者吞咽功能的影响,分析吞咽功能的发展趋势。方法采用便利抽样法,选取2019年1—9月某三甲医院行喉部分切除术的首诊喉癌患者54例为研究对象,其中喉垂直部分切除术患者25例(垂直组),喉声门上水平部分切除术患者12例(水平组)和喉环状软骨上部分切除术17例(SCPL组)。观察患者术后胃管拔除时间,术后15 d行X线吞咽造影检查(VFSS)和改良误侵误吸计分量表(MPAS)评估,术后15、20、30 d采用吞咽评估量表(GUSS)评估3组患者吞咽功能情况。结果3组患者胃管拔除时间、术后15 d GUSS、VFSS+MPAS评分比较差异有统计学意义(P<0.01)。以时间为主效应的Roy最大根检验F=460.693,P<0.001,时间对GUSS评分有影响;以手术为主效应的Roy最大根检验F=218.387,P<0.001,手术方式对GUSS评分有影响;时间与手术方式交互时F=164.033,P<0.001,3组术式不同时间点的吞咽功能发展趋势不一样。结论喉垂直部分切除术对吞咽的影响较小,且恢复较快,喉声门上水平部分切除术和SCPL术对吞咽功能的影响较大,短时间内不能依赖残喉自身的括约肌功能获得较好的代偿,且喉声门上水平部分切除术患者需要更长时间的康复周期。     

Treadmill training with body weight support: its effect on Parkinson's disease

OBJECTIVE: To test whether body weight-supported treadmill training (BWSTT) is effective in improving functional outcome of patients with Parkinson's disease. DESIGN: Prospective crossover trial. Patients were randomized to receive either a 4-week program of BWSTT with up to 20% of their body weight supported followed by 4 weeks of conventional physical therapy (PT), or the same treatments in the opposite order. Medications for parkinsonism were not modified throughout the study. SETTING: Inpatient rehabilitation unit for neurologic diseases. SUBJECTS: Ten patients (5 men, 5 women) with Hoehn and Yahr stage 2.5 or 3 parkinsonism; mean age 67.6 years, mean duration of Parkinson's disease 4.2 years. MAIN OUTCOME MEASURES: The Unified Parkinson's Disease Rating Scale (UPDRS), ambulation endurance and speed (sec/10 m), and number of steps for 10-meter walk. RESULTS: The mean total UPDRS before/after BWSTT was 31.6/25.6, and before/after PT was 29.1/28.0. Analysis of covariance for improvement of UPDRS demonstrated a significant effect of type of therapy (F(1, 16) = 42.779, p < .0001) but not order of therapy (F(1, 16) = 0.157, p = .697 1). Patients also had significantly greater improvement with BWSTT than with PT in ambulation speed (BWSTT, before/after = 10.0/8.3; PT, 9.5/8.9), and number of steps (BWSTT, 22.3/19.6; PT, 21.5/20.8). CONCLUSIONS: In persons with Parkinson's disease, treadmill training with body weight support produces greater improvement in activities of daily living, motor performance, and ambulation than does physical therapy.     

吞咽器官功能训练在老年吞咽障碍患者吞咽功能改善中的应用

目的:探讨实施吞咽器官功能训练对老年吞咽功能障碍患者吞咽功能的改善效果。方法:采用便利抽样法,选取2018年6月—2019年6月北京协和医院老年病房的80例老年吞咽障碍患者作为研究对象,按照随机分组的方式将其分为观察组与对照组,每组各40例。对照组患者给予常规治疗措施,观察组患者在常规治疗的基础上给予为期8周的吞咽器官功能训练。比较两组患者干预前、干预4、8周后的标准吞咽功能评价量表(SSA)得分、洼田饮水试验(WST)结果。结果:干预后,观察组患者干预4、8周后的SSA得分低于对照组,两组得分比较差异均有统计学意义(P<0.05)。观察组患者干预8周后的WST疗效优于对照组,两组比较差异有统计学意义(P<0.05)。结论:吞咽器官功能训练对老年吞咽功能障碍患者具有良好的临床效果,可以提高患者生活质量,促进早日康复,值得在临床中应用推广。     

针刺“吞咽点”治疗脑卒中后吞咽障碍的临床效果

目的观察针刺"吞咽点"治疗脑卒中后吞咽障碍的临床效果。方法选取2014年3月至2017年6月陕西中医药大学第二附属医院针灸康复科及殷克敬工作室收治的60例脑卒中后吞咽障碍患者为研究对象,将其随机分为对照组和观察组,每组30例。对照组给予康复训练,观察组给予针刺"吞咽点"治疗。比较两组患者的洼田饮水试验评分、标准吞咽功能评价量表(SSA)评分以及临床疗效。结果治疗前,两组患者的洼田饮水试验评分比较,差异不具有统计学意义(P>0.05);治疗后,两组患者的洼田饮水试验评分均较治疗前降低,且观察组低于对照组,差异具有统计学意义(P<0.05)。治疗前,两组患者的SSA评分比较,差异无统计学意义(P>0.05);治疗后,两组患者的SSA评分均较治疗前降低,且观察组低于对照组,差异具有统计学意义(P<0.05)。观察组患者的治疗总有效率为96.67%,高于对照组患者的73.33%,差异具有统计学意义(P<0.05)。结论针刺"吞咽点"可显著改善脑卒中患者吞咽功能障碍,值得临床应用和推广。     

早期VitalStim治疗仪联合吞咽康复训练对脑梗死后吞咽障碍康复预后的影响

目的：探究早期VitalStim治疗仪联合吞咽康复训练对脑梗死后吞咽障碍康复预后的影响。方法：选取脑梗死合并吞咽障碍患者96例，随机分为3组，3组均给予脑梗死常规用药治疗，A组采用VitalStim治疗仪给予治疗，B组给予吞咽康复训练的方式给予治疗，C组采用VitalStim治疗仪联合吞咽康复训练的方式给予治疗，对比3组患者吞咽功能、生活质量改善情况以及相关性肺炎（SAP）发生率及营养检测指标的改善情况。结果：治疗后，3组吞咽功能评价量表(SSA)评分均较治疗前下降（P<0.05），且C组更低于其他2组（P<0.05）；治疗后3组生活质量评分均较治疗前提高（P<0.05），C组饮食控制、按时服药、社会功能及心理健康评分更高于A组及B组（P<0.05）；治疗后3组维生素A、维生素E、铁、锌、热量及膳食纤维含量虽然比治疗前有所提升，但差异无统计学意义，3组蛋白质、膳食纤维、维生素C及钙水平较治疗前明显提高（P<0.05），且C组蛋白质、维生素C及钙水平更高于其他2组（P<0.05）；治疗期间及出院后半年内SAP 的发生率比较，C组明显低于其他2组（P<0.05）。结论：通过对脑梗死患者进行早期VitalStim治疗仪联合吞咽康复训练，可以促进患者吞咽功能的恢复，促进患者对营养的摄取，有效改善患者的生活质量并降低SAP发生率。